Four-year outcomes after transcatheter or contemporary surgical aortic valve replacement from the Evolut Low Risk trial
Basel Ramlawi, John K. Forrest(Yale University), Michael J. Reardon(Houston Methodist), Joshua D. Rovin(Morton Plant Hospital), Yoojin Jung(Medtronic (United States)), G. Michael Deeb(University of Michigan), Steven J. Yakubov(OhioHealth), Mubashir Mumtaz(University of Pittsburgh Medical Center), Tanvir Bajwa(Aurora Health Care)
Cited by 5
Related Papers
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
|New England Journal of Medicine|2019|3.6k
Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients
|New England Journal of Medicine|2004|2.9k
Long-Term Results of Carotid Stenting versus Endarterectomy in High-Risk Patients
|New England Journal of Medicine|2008|832
Acute and 12-Month Results With Catheter-Based Mitral Valve Leaflet Repair
|Journal of the American College of Cardiology|2012|567
4-Year Results of a Randomized Controlled Trial of Percutaneous Repair Versus Surgery for Mitral Regurgitation
|Journal of the American College of Cardiology|2013|444